MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, NVCR made $655,353K in revenue. -$136,227K in net income. Net profit margin of -20.79%.

Income Overview

Revenue
$655,353K
Net Income
-$136,227K
Net Profit Margin
-20.79%
EPS
-$1.22
Unit: Thousand (K) dollars
Revenue Breakdown
    • US
    • DE
    • FR
    • Others
Revenue Breakdown
    • Reporting Period
    • Previous Periods

Income Statement
2025-12-31
2024-12-31
Net revenues
655,353 605,220
Cost of revenues
166,879 137,181
Gross profit
488,474 468,039
Research, development and clinical studies
224,544 209,645
Sales and marketing
240,064 239,063
General and administrative
177,666 189,827
Total operating costs and expenses
642,274 638,535
Operating income (loss)
-153,800 -170,496
Financial (expenses) income, net
17,550 39,334
Total income (loss) before income taxes
-136,250 -131,162
Income tax
-23 37,465
Net income (loss)
-136,227 -168,627
Basic EPS
-1.22 -1.56
Diluted EPS
-1.22 -1.56
Basic Average Shares
111,471,991 107,834,368
Diluted Average Shares
111,471,991 107,834,368
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
DE$79,407K (21.67%↑ Y/Y)FR$76,189K (36.71%↑ Y/Y)Other InternationalMarkets$56,898K (33.97%↑ Y/Y)JP$37,786K (16.02%↑ Y/Y)Net income (loss)-$136,227K (19.21%↑ Y/Y)Income tax-$23K (-100.06%↓ Y/Y)US$385,632K (-1.57%↓ Y/Y)International Markets$250,280K (27.67%↑ Y/Y)CN$19,441K (11.82%↑ Y/Y)Total income (loss)before income taxes-$136,250K (-3.88%↓ Y/Y)Financial (expenses)income, net$17,550K (-55.38%↓ Y/Y)Net revenues$655,353K (8.28%↑ Y/Y)Operating income (loss)-$153,800K (9.79%↑ Y/Y)Gross profit$488,474K (4.37%↑ Y/Y)Cost of revenues$166,879K (21.65%↑ Y/Y)Total operating costsand expenses$642,274K (0.59%↑ Y/Y)Sales and marketing$240,064K (0.42%↑ Y/Y)Research, development andclinical studies$224,544K (7.11%↑ Y/Y)General andadministrative$177,666K (-6.41%↓ Y/Y)

NovoCure Ltd (NVCR)

NovoCure Ltd (NVCR)